Literature DB >> 15964163

Inhibition of rat vascular smooth muscle cell proliferation by extract of Ligusticum chuanxiong and Angelica sinensis.

Yong-Zhong Hou1, Guang-Rong Zhao, Ying-Jin Yuan, Guo-Guang Zhu, Raimo Hiltunen.   

Abstract

Ligusticum chuanxiong (LC) and Angelica sinensis (AS) have been widely used as traditional Chinese medicine to treat some pathological settings such as atherosclerosis and hypertension. The aim of this paper is to determine the effects of the extract of LC and AS (ELCAS) on serum-induced vascular smooth muscle cell (VSMC) proliferation, cell cycle and nitric oxide production. The results show that ELCAS significantly inhibited proliferation and protein synthesis of VSMC in a dose and time dependent manner. The cell population assessed by flow cytometry in the G(0)/G(1) phase increased 74% versus 79.8%, concomitant with a decrease in the S phase, 7.4% versus 4.2%, for control versus ELCAS (300 microg/ml). On the other hand, ELCAS significantly increased nitric oxide production of VSMC. The data suggest that ELCAS markedly inhibited VSMC proliferation by arresting G(1) to S progression, which may be associated with nitric oxide production.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964163     DOI: 10.1016/j.jep.2005.01.051

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  15 in total

Review 1.  Biological reactive intermediates (BRIs) formed from botanical dietary supplements.

Authors:  Birgit M Dietz; Judy L Bolton
Journal:  Chem Biol Interact       Date:  2010-10-21       Impact factor: 5.192

2.  Angelica sinensis and its alkylphthalides induce the detoxification enzyme NAD(P)H: quinone oxidoreductase 1 by alkylating Keap1.

Authors:  Birgit M Dietz; Dongting Liu; Ghenet K Hagos; Ping Yao; Andreas Schinkovitz; Samuel M Pro; Shixin Deng; Norman R Farnsworth; Guido F Pauli; Richard B van Breemen; Judy L Bolton
Journal:  Chem Res Toxicol       Date:  2008-09-23       Impact factor: 3.739

3.  Antibacterial and anti-inflammatory activity of traditional Chinese herb pairs, Angelica sinensis and Sophora flavescens.

Authors:  Chunchao Han; Jianyou Guo
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

4.  The anti-inflammatory effect of Z-Ligustilide in experimental ovariectomized osteopenic rats.

Authors:  Zhaoji Ma; Lunhao Bai
Journal:  Inflammation       Date:  2012-12       Impact factor: 4.092

Review 5.  Recent Progress of Research on Herbal Products Used in Traditional Chinese Medicine: the Herbs belonging to The Divine Husbandman's Herbal Foundation Canon ( Shén Nóng Běn Cǎo Jīng).

Authors:  Kuo-Hsiung Lee; Susan Morris-Natschke; Keduo Qian; Yizhou Dong; Xiaoming Yang; Ting Zhou; Eileen Belding; Shou-Fang Wu; Koji Wada; Toshiyuki Akiyama
Journal:  J Tradit Complement Med       Date:  2012-01

Review 6.  Anti-Hypertensive Herbs and Their Mechanisms of Action: Part II.

Authors:  M Akhtar Anwar; Sara S Al Disi; Ali H Eid
Journal:  Front Pharmacol       Date:  2016-03-08       Impact factor: 5.810

7.  Trends in the treatment of hypertension from the perspective of traditional chinese medicine.

Authors:  Xingjiang Xiong; Xiaochen Yang; Wei Liu; Fuyong Chu; Pengqian Wang; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-26       Impact factor: 2.629

8.  Comparison of ferulic acid content in Radix Angelicae Sinensis, Danggui-Buxue-Tang and Danggui-Sini-Tang.

Authors:  Jia-Mei Yao; Li-Jin Yu; Qiong Chen; Ze-Qi Chen; Dong-Sheng Wang; Xin-Jian Qiu; Lin-Lin Zhao
Journal:  Exp Ther Med       Date:  2014-02-14       Impact factor: 2.447

Review 9.  Traditional chinese medicine syndromes for essential hypertension: a literature analysis of 13,272 patients.

Authors:  Jie Wang; Xingjiang Xiong; Wei Liu
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-10       Impact factor: 2.629

10.  Effect of ligustilide on Ang II-induced hypertrophy in cardiomyocytes and the potential mechanisms.

Authors:  Qun Lu; Shaohong Luo; Yongfang Wen
Journal:  Exp Ther Med       Date:  2014-04-24       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.